THOMAS M. WOLF

Corporate Board Profile

Tech Score: 0/100

GT Biopharma, Inc.

Filing Date	Source Excerpt
2002-04-29	Thomas M. Wolf Age: 58 Director. Since 1997 Mr. Wolf has served as the Chief Executive Officer and Managing Director of Xenos Bioresources, Inc., an importer of pharmaceutical and nutraceutical raw materials. ... Member of Audit and Compensation Committees; Mr. Wolf was appointed to the Audit and Compensation Committees on April 8, 2002.
2003-04-30	Thomas M. Wolf Age: 59 Director. Since 1997 Mr. Wolf has served as the Chief Executive Officer and Managing Director of Xenos Bioresources, Inc., an importer of pharmaceutical and nutraceutical raw materials. ... Members of this committee are Richard A. Davis, Stuart S. Lang, Tom Wolf, and William G. Pryor, who assumed his committee membership in November 2002 when he was appointed to the Board. He is also a member of the Audit Committee. ... The Company pays an annual fee of $4,000 to each non-employee director and an additional $1,000 to non-employee directors for serving as committee chair. During 2002, OXIS did not make payments under this policy. Payments will resume in 2003.

Filing Date

Source Excerpt

2002-04-29

Thomas M. Wolf Age: 58 Director. Since 1997 Mr. Wolf has served as the Chief Executive Officer and Managing Director of Xenos Bioresources, Inc., an importer of pharmaceutical and nutraceutical raw materials. ... Member of Audit and Compensation Committees; Mr. Wolf was appointed to the Audit and Compensation Committees on April 8, 2002.

2003-04-30

Thomas M. Wolf Age: 59 Director. Since 1997 Mr. Wolf has served as the Chief Executive Officer and Managing Director of Xenos Bioresources, Inc., an importer of pharmaceutical and nutraceutical raw materials. ... Members of this committee are Richard A. Davis, Stuart S. Lang, Tom Wolf, and William G. Pryor, who assumed his committee membership in November 2002 when he was appointed to the Board. He is also a member of the Audit Committee. ... The Company pays an annual fee of $4,000 to each non-employee director and an additional $1,000 to non-employee directors for serving as committee chair. During 2002, OXIS did not make payments under this policy. Payments will resume in 2003.

Data sourced from SEC filings. Last updated: 2025-10-12